Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Dasatinib
Sponsor: M.D. Anderson Cancer Center
Collaborators: Susan G. Komen Breast Cancer Foundation|Bristol-Myers Squibb